Cann Group Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: 0.000x

Cann Group Ltd cash flow conversion efficiency. Based on the latest financial reports, Cann Group Ltd (CAN) has a cash flow conversion efficiency ratio of 0.000x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-11.00K ≈ $-7.78K USD) by net assets (AU$34.16 Million ≈ $24.17 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Cann Group Ltd (2015–2025)

Cash flow conversion efficiency of Cann Group Ltd from 2015 to 2025. This chart illustrates how Cann Group Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Cann Group Ltd for real-time trading data and today's change.

Cann Group Ltd Cash Flow Conversion Ratio Explained

Cann Group Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Cann Group Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cann Group Ltd ranked by their cash flow conversion efficiency. Also see market value of Cann Group Ltd for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Ahlada Engineers Limited
NSE:AHLADA
0.024x
Austchina Holdings Ltd
AU:AUH
-0.034x
Macarthur Minerals Ltd
AU:MIO
-0.005x
Identitii Ltd
AU:ID8
-0.536x
ESE Entertainment Inc
V:ESE
-0.052x
Australasian Metals Ltd
AU:A8G
-0.053x
abrdn Asian Income Fund Limited
LSE:AAIF
0.031x
Celtic plc
LSE:CCPC
-0.038x

Annual Cash Flow Conversion Efficiency for Cann Group Ltd (2015–2025)

The table below shows the annual cash flow conversion efficiency of Cann Group Ltd from 2015 to 2025. Review CAN FCF to total liabilities ratio to assess the company's free cash flow relative to its total liabilities.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$-2.77 Million
≈ $-1.96 Million
AU$-9.64 Million
≈ $-6.82 Million
3.475x +418.57%
2024-06-30 AU$13.92 Million
≈ $9.85 Million
AU$-15.19 Million
≈ $-10.74 Million
-1.091x -183.08%
2023-06-30 AU$59.26 Million
≈ $41.93 Million
AU$-22.84 Million
≈ $-16.16 Million
-0.385x -60.11%
2022-06-30 AU$84.90 Million
≈ $60.07 Million
AU$-20.43 Million
≈ $-14.46 Million
-0.241x -6.15%
2021-06-30 AU$91.87 Million
≈ $65.01 Million
AU$-20.83 Million
≈ $-14.74 Million
-0.227x +21.40%
2020-06-30 AU$61.07 Million
≈ $43.21 Million
AU$-17.62 Million
≈ $-12.47 Million
-0.288x -200.42%
2019-06-30 AU$77.30 Million
≈ $54.69 Million
AU$-7.42 Million
≈ $-5.25 Million
-0.096x -119.63%
2018-06-30 AU$85.87 Million
≈ $60.76 Million
AU$-3.75 Million
≈ $-2.66 Million
-0.044x +72.12%
2017-06-30 AU$14.66 Million
≈ $10.37 Million
AU$-2.30 Million
≈ $-1.63 Million
-0.157x +78.75%
2016-06-30 AU$1.69 Million
≈ $1.20 Million
AU$-1.25 Million
≈ $-882.14K
-0.738x +25.57%
2015-06-30 AU$648.33K
≈ $458.73K
AU$-642.74K
≈ $-454.78K
-0.991x --

About Cann Group Ltd

AU:CAN Australia Drug Manufacturers - Specialty & Generic
Market Cap
$5.87 Million
AU$8.30 Million AUD
Market Cap Rank
#28526 Global
#1491 in Australia
Share Price
AU$0.01
Change (1 day)
+0.00%
52-Week Range
AU$0.00 - AU$0.01
All Time High
AU$3.98
About

Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia.